Eli Lilly and Regeneron are leading the push to treat congenital deafness with gene therapies, seeking a piece of a potential ...

The patient-therapist alliance has long been known to be a critical component of successful outcomes in therapy. A new study ...

Explore cancer drug resistance and its significant impact on treatment options and patient outcomes in modern cancer therapy.

A clinical-stage biotechnology company developing small-molecule therapies targeting amyloid beta (Aβ) for neurodegenerative ...

Chandigarh: At the inaugural session of the ISTS Annual Conference 2026, Prof. Vivek Lal described transplantation as the ...

Opportunities in the pain market include developing NaV inhibitors like NaV1.8 and NaV1.7, diversifying pain therapeutics by molecule type, and capitalizing on the fast-growing nociceptive pain sector ...

Bridging therapy was administered to 90% of apheresed patients, with chemotherapy ± radiotherapy used in 53% and targeted ...

Click in for more news from The Hill{beacon}View Online Health Care Health Care   The Big Story Federal judge rules RFK Jr.

Coming up: Science on Tap: Abs, Apple Watches, and Other Lies on the Malvern Patch calendar ...

A federal judge in Oregon on March 19 blocked a “declaration” issued by the Trump administration’s Department of Health and ...

As programs continually review quantitative and qualitative information related to program outcomes and viability, it is sometimes necessary to deactivate an online modality for an existing program.

According to the National Alliance on Mental Illness, 838,000 adults in Louisiana were living with a mental health condition ...